Early Phase 1 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a healthy woman between the ages of 18 and 55
- Your body mass index (BMI) falls between 18 and 30 (a standard measure of body weight relative to height)
- Your skin tone falls within a light to medium range on a standard skin classification scale known as Fitzpatrick Types I–IV (confirm with trial site)
- Your scalp is healthy, with no irritation, skin conditions, or damage
- You are willing and able to avoid using other products on your scalp during the trial
Who may not be able to join:
- You have a history of heart disease, high blood pressure, or irregular heartbeat
- You currently have a scalp infection, open wounds on the scalp, or significant hair loss
- You have recently used certain medications that affect how the body processes drugs (confirm with trial site which medications apply)
- You have a known allergy or sensitivity to phenylephrine (a decongestant ingredient) or ethanol (alcohol)
- You tested positive on a drug screening test or had an abnormal heart reading (ECG) during the initial check-in
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andy Goren, MD, University of Rome G. Marconi
Phone: 16507040850
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pharmacokinetic profile of phenylephrine
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.